Skip to main content

TEVA 33 09 Pill - white capsule/oblong, 19mm

Pill with imprint TEVA 33 09 is White, Capsule/Oblong and has been identified as Theophylline Extended-Release 450 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Theophylline is used in the treatment of Asthma; Apnea of Prematurity; Asthma, acute; Asthma, Maintenance and belongs to the drug class methylxanthines. Risk cannot be ruled out during pregnancy. Theophylline 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 33 09

Theophylline extended-release 450 mg TEVA 33 09

Theophylline Extended-Release

Imprint
TEVA 33 09
Strength
450 mg
Color
White
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Methylxanthines
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
Manufacturer
Watson Pharma Private Limited
National Drug Code (NDC)
00480-3309

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.